Literature DB >> 1990952

Airways inflammation in nocturnal asthma.

R J Martin1, L C Cicutto, H R Smith, R D Ballard, S J Szefler.   

Abstract

Nocturnal asthma is a frequent problem, but the mechanism is unclear. We investigated the possibility that airways inflammation occurred during the night. Bronchoalveolar lavage fluid was analyzed in asthmatic patients with (n = 7) and without nocturnal asthma (n = 7) at 1600 and 0400 h. The nocturnal asthma group had an increase in the total leukocyte count (24.0 +/- 7.0 to 41.1 +/- 9.9 x 10(4) cells/ml, p less than 0.05), neutrophils (1.1 +/- 0.6 to 3.7 +/- 1.5 x 10(4) cells/ml, p less than 0.05), and eosinophils (0.5 +/- 0.1 to 1.7 +/- 0.7 x 10(4) cells/ml, p less than 0.05) from 1600 to 0400 h. Cellular components for the non-nocturnal asthma group did not change. Between groups, the 1600-h cells were similar. At 0400 h the nocturnal asthma group had significantly higher total leukocyte, neutrophil, eosinophil, lymphocyte, and epithelial cell counts. For all subjects, the overnight fall in peak expiratory flow rates was correlated to the change in neutrophils (r = 0.54, p less than 0.05) and eosinophils (r = 0.77, p less than 0.05). We conclude that the nocturnal worsening of asthma has an associated cellular inflammatory response that is not seen in patients without overnight decrements in lung function. This inflammatory response together with epithelial damage may be important factors in the etiology of nocturnal asthma.

Entities:  

Mesh:

Year:  1991        PMID: 1990952     DOI: 10.1164/ajrccm/143.2.351

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  31 in total

1.  Nocturnal asthma.

Authors:  J B MacDonald
Journal:  BMJ       Date:  1992-04-18

2.  Neutrophil airway inflammation in childhood asthma.

Authors:  C M McDougall; P J Helms
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

Review 3.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

4.  Semaphorin3E/plexinD1 Axis in Asthma: What We Know So Far!

Authors:  Latifa Koussih; Abdelilah S Gounni
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Treatment of nocturnal asthma with nedocromil sodium.

Authors:  L Clancy; S Keogan
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

Review 6.  Neutrophils in asthma.

Authors:  Ana L Macdowell; Stephen P Peters
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

7.  Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.

Authors:  J Turki; J Pak; S A Green; R J Martin; S B Liggett
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Role of inflammation in nocturnal asthma.

Authors:  T W Mackay; W A Wallace; S E Howie; P H Brown; A P Greening; M K Church; N J Douglas
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

9.  Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.

Authors:  C J Whelan; M Johnson
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

10.  Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals.

Authors:  H Cullup; P G Middleton; G Duggan; J S Conn; A M Dickinson
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.